Yatharth Hospital & Trauma Care Services Limited has released the transcript of their Q4 FY26 earnings conference call, which took place on May 26, 2026. The call followed the declaration of the company's audited financial results for the quarter and financial year ended March 31, 2026. During the call, management highlighted that FY26 was a transformative year, with consolidated revenue reaching approximately INR 12,072 million (₹1207.2 crore), a robust 36% year-over-year growth. EBITDA increased by 30% YoY to INR 2,921 million (₹292.1 crore). The company reported a Q4 FY26 revenue of INR 3,416 million (₹341.6 crore), a 47% YoY growth. EBITDA for Q4 FY26 was INR 799 million (₹79.9 crore), with an EBITDA margin of 23.4%. Profit after tax for Q4 FY26 stood at INR 447 million (₹44.7 crore), up 15% YoY, while FY26 PAT was INR 1,703 million (₹170.3 crore), a 30% YoY growth. Key operational highlights included the acquisition of an ultra-modern super-speciality hospital in Gurugram for approximately INR 100 crore, with an additional INR 100 crore investment planned for finishing and infrastructure. This hospital is expected to be operational by April 2027 and achieve an Average Revenue Per Bed (ARPOB) exceeding INR 50,000. The company also successfully integrated the 250-bedded Agra hospital, which is achieving a monthly revenue run rate of approximately INR 7 crore and double-digit EBITDA margins. The company aims to reach 5,000 beds within the next three years, with approximately 70% expected from acquisitions and 30% from greenfield development. The management discussed improvements in ARPOB, with Noida Extension and Greater Noida hospitals showing significant increases. They also addressed debt levels, stating that total debt is around INR 230 crore, with a net cash position of INR 1,160 million (₹116 crore). The company expects to sustain healthy growth momentum, with EBITDA margins projected to remain around 24-25% and revenue growth expected to surpass the 36% YoY growth seen in FY26. New Delhi and Faridabad Sector 20 hospitals are anticipated to achieve EBITDA breakeven in H2 FY27. Debtor days are targeted to reduce to 90-95 days by the end of FY27 from 112 days in FY26. The transcript also covers discussions on corporate governance enhancements, including the appointment of BDO International as statutory auditors and Deloitte as internal auditors. Management also provided insights into the payer mix, aiming to reduce government business to around 25% in the next two financial years, and addressed the impact of the West Asia crisis on international patient numbers, with a focus on strengthening presence in the African market.
